Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Total Liabilities (2020 - 2023)

Terns Pharmaceuticals (TERN) has disclosed Total Liabilities for 4 consecutive years, with $13.3 million as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Total Liabilities rose 49.15% year-over-year to $13.3 million, compared with a TTM value of $13.3 million through Sep 2023, up 49.15%, and an annual FY2022 reading of $10.1 million, up 29.82% over the prior year.
  • Total Liabilities was $13.3 million for Q3 2023 at Terns Pharmaceuticals, down from $15.5 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $119.8 million in Q3 2020 and bottomed at $6.7 million in Q2 2021.
  • Average Total Liabilities over 4 years is $30.7 million, with a median of $10.1 million recorded in 2022.
  • The sharpest move saw Total Liabilities plummeted 93.89% in 2021, then surged 103.39% in 2023.
  • Year by year, Total Liabilities stood at $23.7 million in 2020, then plummeted by 67.23% to $7.8 million in 2021, then rose by 29.82% to $10.1 million in 2022, then soared by 31.53% to $13.3 million in 2023.
  • Business Quant data shows Total Liabilities for TERN at $13.3 million in Q3 2023, $15.5 million in Q2 2023, and $13.6 million in Q1 2023.